Journal of Clinical and Cellular Immunology : Citations & Metrics Report
Articles published in Journal of Clinical and Cellular Immunology have been cited by esteemed scholars and scientists all around the world. Journal of Clinical and Cellular Immunology has got h-index 42, which means every article in Journal of Clinical and Cellular Immunology has got 42 average citations.
Following are the list of articles that have cited the articles published in Journal of Clinical and Cellular Immunology.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
30 | 31 | 30 | 59 | 28 | 11 | 35 | 56 | 95 | 105 | 101 | 105 | 64 | 15 | 3 |
Research, Review articles and Editorials |
2 | 13 | 8 | 23 | 18 | 8 | 25 | 35 | 54 | 86 | 79 | 35 | 23 | 14 | 3 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 18 | 22 | 22 | 10 | 3 | 10 | 21 | 39 | 6 | 9 | 7 | 1 | 1 | 0 |
Conference proceedings |
0 | 16 | 15 | 6 | 0 | 98 | 178 | 206 | 171 | 160 | 195 | 156 | 74 | 0 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
653 | 826 | 931 | 1079 | 1018 | 971 | 871 | 851 | 753 | 550 | 276 | 145 | 43 | 40 | 0 |
| Journal total citations count | 8361 |
| Journal impact factor | 24.12 |
| Journal 5 years impact factor | 31.14 |
| Journal cite score | 30.45 |
| Journal h-index | 42 |
| Journal h-index since 2019 | 32 |
Important citations (1511)
Vaccine development for rheumatoid arthritis |
|
Vaccine development for rheumatoid arthritis |
|
U0126, an inhibitor of mek1/2, increases tumor necrosis factor-?-induced apoptosis, but not interleukin-6 induced apoptosis in c-28/i2 human chondrocytes |
|
malemud cj (2014) the clinical efficacy of a jak3-selective small molecule inhibitor, tofacitinib. rheumatoid arthritis. austin j clin immunol 1: 1021. |
|
malemud cj (2015) chondrocyte apoptosis in rheumatoid arthritis: is preventive therapy possible?. immunotherapy 1. |
|
Domingo-gonzalez r, martÃnez-colón gj, smith aj, smith ck, ballinger mn, et al (2016). inhibition of neutrophil extracellular trap formation after stem cell transplant by prostaglandin e2. american journal of respiratory and critical care medicine 193:186-97. |
|
wylie ma, malemud cj (2013) deregulation of apoptosis in arthritis by altered signal transduction. int j clin rheumatol 8: 483-490. |
|
malemud cj (2013) regulation of chondrocyte matrix metalloproteinase gene expression. inproteases in health and disease 63-77. |
|
malemud cj (2013) regulation of chondrocyte matrix metalloproteinase gene expression. inproteases in health and disease 63-77. |
|
malemud cj (2013) suppression of pro-inflammatory cytokines via targeting of stat-responsive genes. intech open access publisher. |
|
Kamen dl, oates jc (2015) a pilot study to determine if vitamin d repletion improves endothelial function in lupus patients. the american journal of the medical sciences 350:302-7. |
|
malemud cj (2013) intracellular signaling pathways in rheumatoid arthritis. j clin cel immunol 4: 160. |
|
malemud cj (2015) the pi3k/akt/pten/mtor pathway: a fruitful target for inducing cell death in rheumatoid arthritis?. fut med chem 7: 1137-1147. |
|
Azrielant s, shoenfeld y (2016). eppur si muove: vitamin d is essential in preventing and modulating sle. lupus 25:563-72. |
|
Awasthi d, nagarkoti s, kumar a, dubey m, singh ak, et al (2016) oxidized ldl induced extracellular trap formation in human neutrophils via tlr-pkc-irak-mapk and nadph-oxidase activation. free radical biology and medicine 93:190-203. |
|
Skovbakke sl, heegaard pm, larsen cj, franzyk h, forsman h, et al. (2015). the proteolytically stable peptidomimetic pam-(lys-βnspe) 6-nh 2 selectively inhibits human neutrophil activation via formyl peptide receptor 2. biochemical pharmacology 93:182-95. |
|
(2012) construction and identification of recombinant human type 5 adenovirus with classical swine fever virus e2 protein gene. chin j biolog 7: 004. |
|
balint jp, gabitzsch es, rice a, latchman y, xu y, et al. (2015) extended evaluation of a phase 1/2 trial on dosing, safety, immunogenicity, and overall survival after immunizations with an advanced-generation ad5 [e1-, e2b-]-cea (6d) vaccine in late-stage colorectal cancer. can immunol immunother 64: 977-987. |
|
gabitzsch es, tsang ky, palena c, david jm, fantini m, et al. (2015) the generation and analyses of a novel combination of recombinant adenovirus vaccines targeting three tumor antigens as an immunotherapeutic. oncotarget 6: 31344. |
|
Li s, yu y, koehn cd, zhang z, su k (2013). galectins in the pathogenesis of rheumatoid arthritis. journal of clinical & cellular immunology 4: 5. |
|